Apremilast Accord
Apremilast Accord is a generic from Accord Healthcare AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 131.05 to CHF 259.85 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Accord Healthcare AG
- ATC code
- L04AA32
- IT group
- 07.15 Immunosuppressive Stoffe
- Active substances
- Apremilastum
- Preparation type
- Generic
- On the SL since
- 01/09/2026
- Last price change
- 01/09/2026
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Filmtabl 30 mg | 56 Stk | CHF 219.23 | CHF 259.85 | 01/09/2026 | B | 7680703000021 |
| Starterpackung Filmtabl 4x10,4x20,19x30mg | 27 Stk | CHF 103.22 | CHF 131.05 | 01/09/2026 | B | 7680703000014 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Für alle vergütungspflichtigen Indikationen gilt:
APREMILAST ACCORD darf nicht in Kombination mit Biologika zu Lasten der OKP verordnet werden.
Die Verschreibung von APREMILAST ACCORD für die folgenden Behandlungen kann nur durch Fachärzte der Dermatologie oder Rheumatologie oder dermatologische bzw. rheumatologische Universitätskliniken/Polikliniken erfolgen.
Aktive Psoriasis-Arthritis
Behandlung erwachsener Patienten mit aktiver Psoriasis-Arthritis als Monotherapie oder in Kombination mit DMARDs (z. Bsp. Methotrexat), wenn das Ansprechen auf eine vorhergehende Therapie mit krankheitsmodifizierenden Antirheumatika (DMARDs) unzureichend gewesen ist.
Schwere Plaque Psoriasis
Behandlung erwachsener Patienten mit schwerer Plaque-Psoriasis, bei denen eine Phototherapie oder eine der folgenden konventionellen systemischen Therapien (Ciclosporin, Methotrexat, Acitretin) keinen therapeutischen Erfolg gezeigt haben. Falls nach 24 Wochen kein therapeutischer Erfolg eingetreten ist, ist die Behandlung abzubrechen.
More preparations in this group
FAQ
Is Apremilast Accord covered by Swiss health insurance?
Yes, but only under conditions. Apremilast Accord is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Apremilast Accord cost in Switzerland?
The public price is the maximum price set by the FOPH and for Apremilast Accord ranges from CHF 131.05 to CHF 259.85 per pack. The ex-factory price ranges from CHF 103.22 to CHF 219.23. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages